U-Innovent uzosebenzisana ne-NeoCura e-China ukuhlola ukuphepha, i-pharmacokinetics, i-pharmacodynamics kanye nempumelelo yokuqala yokwelapha okuhlangene kusetshenziswa i-sintilimab evela ku-Innovent kanye ne-NEO_PLIN2101 evela ku-NeoCura ezigulini ezinomdlavuza, ukuze kuthuthukiswe ukuthuthukiswa komtholampilo kwe-immunotherapy ehlangene yezimila eziningi eziqinile futhi zilungiselele ukuhambisa. isicelo somuthi omusha wokuphenya (IND) ku-National Medical Products Administration (NMPA) maduze nje.
UDkt. Liu Yongjun, uMongameli we-Innovent, uthe: “Sihlabeke umxhwele ngepayipi le-R&D elihlukanisiwe le-NeoCura kanye nethimba labacwaningi bamazwe ngamazwe, futhi siyajabula ukungena kulokhu kubambisana okunesu lokuhlola ukubaluleka komtholampilo kwe-sintilimab kuhlanganiswe nemithi yokugomela i-neoantigen yezimila eziqinile. . I-Innovent inepayipi eliqinile elinamakhono aqinile ku-immunology kanye nebhayoloji yomdlavuza. Njengamanje, sinemithi emihlanu emisha egunyaziwe futhi yethulwa e-China futhi izoba nemithi emisha engaphezu kwe-10 ezokwethulwa eminyakeni emi-2-3 ezayo. Inkundla yethu edidiyelwe ngokugcwele iqongelele i-R&D eqinile, ukuthuthukiswa kwemitholampilo namandla okudayisa futhi ilungele ozakwethu ekhaya naphesheya. Sithemba futhi ukuqhubekisela phambili ukuhlola amathuba amasha ekwandiseni izinkomba kanye nokuthuthukisa ukusebenza ngempumelelo kokwelapha kwe-sintilimab ngokuhlanganiswa nezindlela zokwelapha ezintsha. Sibheke ngabomvu ukusebenzisana okubanzi nokujulile phakathi kwamaqembu amabili esikhathini esizayo. “
UDkt. Wang Yi, umsunguli we-NeoCura, wathi: “Okwamanje, imigomo ye-neoantigen iyindlela yokwelapha evelayo enenguquko emhlabeni wonke. I-NeoCura ibigxile ku-R&D yemithi yokugomela i-tumor neoantigen selokhu yasungulwa, ngethemba lokunqoba izinselelo ezikhona zokwelashwa kwamasosha omzimba ekwelapheni izimila eziqinile ngokusetshenziswa kobuchwepheshe obusha. Ukusebenzisana no-Innovent kuzodlala indima ehlangene yokugomela i-neoantigen yomuntu siqu kanye nezidakamizwa ze-monoclonal antibody futhi kuhlole ngokuhlanganyela umphumela womtholampilo wokwelapha okuhlangene ekwelapheni izimila eziqinile, okulindeleke ukuthi kuthuthukiswe izinga lokuphendula kwenhloso ye-immunotherapy futhi ilethe amathuba amasha. ngemithi ehlanganisa umdlavuza.”